Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.

Item

http://www.wikidata.org/entity/Q38113247

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Assessment and management of l ...... ents with high blood pressure.

@en

type

Item

label

Assessment and management of l ...... ents with high blood pressure.

@en

prefLabel

Assessment and management of l ...... ents with high blood pressure.

@en

P1476

Assessment and management of l ...... ents with high blood pressure.

@en

P2860

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study.

Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients.

Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides.

Recommendations for chamber quantification.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

P304

719-728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERC.13.36

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pamela Maffioli

Giuseppe Derosa

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23750681

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes